Incidence and baseline predictors of discontinuation in DRCRnet studies - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prevalence and Initial Predictors of Treatment Discontinuation in DRCRnet Research Studies

  • By

  • Klyve N. Otinkorang

  • Gui-shuang Ying

  • September 11, 2026

Share

Objective:

To assess discontinuation rates and identify baseline predictors of treatment discontinuation in diabetic retinopathy (DR) studies using DRCRnet datasets.

Approach:
  • Study Design: Secondary analysis of publicly available, de-identified data from 19 DRCRnet studies conducted from 2003 to 2020.
  • Outcome Measure: Discontinuation defined as participant departure from a study before completion, excluding deaths.
  • Statistical Analysis: Univariable and multivariable logistic regression analyses were performed to identify predictors of discontinuation.
Key Findings:
  • Out of 7770 participants, 7353 were included after exclusions, resulting in a discontinuation rate of X%.
  • Demographic and clinical characteristics were analyzed to identify predictors of discontinuation, including age, sex, race/ethnicity, and baseline health conditions.
Limitations:
  • The analysis is based on secondary data, which may have inconsistencies.
  • Certain health conditions (e.g., dyslipidaemia) had incomplete data.
Conclusion:

Identifying predictors of treatment discontinuation can provide insights into participant retention in diabetic retinopathy research.

Sources:

Original Source(s)

Incidence and baseline predictors of discontinuation in DRCRnet studies

  • by Klyve N. Otinkorang, Gui-shuang Ying

  • September 11, 2026

Related Content

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.

Are GLP-1s Linked to Optic Neuropathy?

A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.

Mitochondrial DNA Variation, Antiretroviral Therapy, and Incidence of Diabetes Among Men With and Without HIV